Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mayada Said"'
Autor:
Mayada Said, Khaled M. Ali, Munerah M. Alfadhel, Obaid Afzal, Basmah Nasser Aldosari, Maha Alsunbul, Rawan Bafail, Randa Mohammed Zaki
Publikováno v:
International Journal of Pharmaceutics: X, Vol 8, Iss , Pp 100293- (2024)
This study aimed to formulate and statistically optimize spanlastics loaded spongy insert (SPLs-SI) of prednisolone Na phosphate (PRED) to enhance and sustain its anti-inflammatory effect in a controlled manner. An I-optimal optimization was employed
Externí odkaz:
https://doaj.org/article/ec91a407bd4b4951aa3b49de5563101c
Autor:
Randa Mohammed Zaki, Layla A. Alkharashi, Omnia M. Sarhan, Alanood S. Almurshedi, Basmah Nasser Aldosari, Mayada Said
Publikováno v:
International Journal of Pharmaceutics: X, Vol 6, Iss , Pp 100208- (2023)
This study aimed to formulate and statistically optimize cubosomal formulations of metformin (MTF) to enhance its breast anticancer activity. A Box Behnken design was employed using Design-Expert® software. The formulation variables were glyceryl mo
Externí odkaz:
https://doaj.org/article/0bf67e237d0d41b497da6dd57e77dccc
Autor:
Randa Mohammed Zaki, Vidya Devanathadesikan Seshadri, Alanoud S. Mutayran, Lara A. Elsawaf, Abubaker M. Hamad, Alanood S. Almurshedi, Rehab Mohammad Yusif, Mayada Said
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2521 (2022)
This study aimed to make a formulation and statistical optimization of transethosomal formulations of rosuvastatin (ROS) to enhance its topical wound healing efficiency. Design-Expert® software was used to employ I optimal design. The formulation va
Externí odkaz:
https://doaj.org/article/695763df0ba8490db7707e2677954ee9
Autor:
Randa Mohammed Zaki, Munerah M. Alfadhel, Manal A. Alossaimi, Lara Ayman Elsawaf, Vidya Devanathadesikan Seshadri, Alanood S. Almurshedi, Rehab Mohammad Yusif, Mayada Said
Publikováno v:
Pharmaceuticals, Vol 15, Iss 8, p 940 (2022)
This study aimed to formulate and statistically optimize glycerosomal formulations of Quetiapine fumarate (QTF) to increase its oral bioavailability and enhance its brain delivery. The study was designed using a Central composite rotatable design usi
Externí odkaz:
https://doaj.org/article/4f02f23c4ddc4fb5b1713e75308e3c9a
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 1159-1169 (2017)
Agomelatine is a new antidepressant having very low oral drug bioavailability less than 5% due to being liable to extensive hepatic 1st pass effect. This study aimed to deliver agomelatine by transdermal route through formulation and optimization of
Externí odkaz:
https://doaj.org/article/bcf1040311984d2aa9ddaccdb734ccee
Publikováno v:
Journal of Drug Delivery Science and Technology. 61:102075
This study aimed to formulate and statistically optimize cubosomal formulations loaded with voriconazole to enhance and control its ocular bioavailability. The independent variables of the employed central composite face-centered design were the perc